India, May 31 -- Eli Lilly and Co. (LLY) announced results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo (selpercatinib) as adjuvant therapy versus placebo in patients with early-stage (IB-I... Read More
India, May 31 -- South Korea posted a seasonally adjusted merchandise trade surplus of $26.95 billion in May, Statistics Korea said on Monday.That beat expectations for a surplus of $24.30 billion and... Read More
India, May 31 -- The manufacturing sector in Australia continued to expand in May, albeit at a slower rate, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 50.7.... Read More
India, May 31 -- Jennifer Lopez's "On the Floor," featuring Pitbull, has returned to the Billboard charts. The song returns at No. 117 on the Billboard Global 200 chart and No. 80 on the Billboard Gl... Read More
India, May 30 -- MannKind Corp. (MNKD) announced that the U.S. Food and Drug Administration approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 and older livi... Read More
India, May 30 -- Oculis Holding AG (OCS) announced that its Phase 3 DIAMOND-1 and DIAMOND-2 trials of OCS-01 eye drops in patients with diabetic macular edema (DME) did not achieve the primary endpoin... Read More
India, May 30 -- June's FDA calendar offers plenty for investors to keep a close eye on. Among the key names are Spero Therapeutics, awaiting an FDA decision on its antibiotic for complicated urinary ... Read More
India, May 30 -- After a long 15-year association, acclaimed singer-songwriter Ed Sheeran has left Warner Music Group. Sheeran released eight full-length albums with WMG's affiliate label Asylum Reco... Read More
India, May 30 -- The Red Clay Strays, who were honored as Group of the Year at the 61st Academy of Country Music Awards last week, have announced they will play a live show June 3rd at Nashville's The... Read More
India, May 30 -- Pfizer Inc. (PFE) announced detailed results from the pivotal Phase 3 TALAPRO-3 study evaluating TALZENNA (talazoparib), an oral PARP inhibitor, in combination with XTANDI (enzalutami... Read More